Norges Bank
INBX icon

Norges Bank’s Inhibrx INBX Stock Holding History

Norges Bank’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.56M Buy
+90,300
New +$9.05M ﹤0.01% 1308
2026
Q1 		– Sell
-133,300
Closed -$10.5M – 671
2025
Q4 		$10.5M Buy
+133,300
New +$9.08M ﹤0.01% 1291

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Norges Bank's INBX Position: Q2 2026 in Review

Norges Bank opened a new position in Inhibrx (INBX) in Q2 2026: 90,300 shares worth $8.56M. The stake represents ﹤0.01% of the portfolio and ranks #1308 among its holdings. This is a return to the name: Norges Bank previously reported a position in INBX as recently as Q4 2025.

Norges Bank first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $10.5M in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Norges Bank held 90,300 shares of Inhibrx worth $8.56M as of Q2 2026.
  • Inhibrx was a new Norges Bank position in Q2 2026.
  • Inhibrx made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1308 holding.
  • Norges Bank first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • Norges Bank's Inhibrx position peaked at $10.5M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.